Crossmark

Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results.

Crossref DOI link: https://doi.org/10.1186/s12917-018-1722-7

Published Online: 2019-01-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fischer, Britta M.

McMullen, Richard J. Jr https://orcid.org/0000-0002-0635-0883
Reese, Sven

Brehm, Walter
License Information

Text and Data Mining valid from 2019-01-16
More Information

Article History

Received: 16 August 2018

Accepted: 29 November 2018

First Online: 16 January 2019

Ethics approval and consent to participate

: Owners were educated on the various medical and surgical (i.e., PPV, CSI, and intravitreal injections) treatment options, and risks associated with each option. Verbal client consent to perform the IVGI was obtained following an in-depth discussion of potential complications including failure of the selected treatment option to control the disease, resulting in persistent/ recurrent inflammation with progression of ocular signs, and potential cataract maturation or development and retinal degeneration or detachment.

: not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.